Cost-effectiveness of a national population-based screening program for type 2 diabetes: the Brazil experience.

CONCLUSIONS: In the base case analysis, not considering the intangible benefit of transferring diabetes management to primary care nor the benefit of using statin to treat eligible diabetic patients, CE ratios were not cost-effective considering thresholds proposed by the World Health Organization. However, significant uncertainty was demonstrated in sensitivity analysis. Our results indicate that policy-makers should carefully balance the benefit and cost of the program while considering using a population-based approach to screen for diabetes. PMID: 26523154 [PubMed]
Source: Diabetes Metab - Category: Endocrinology Authors: Tags: Diabetol Metab Syndr Source Type: research